Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.43 |
| ▸ | TSHR | P16473 | 3/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | PPARD | Q03181 | 2/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL632894 | 0.97 | ALDH1A1 (0.50) | ALDH1A1CYP3A4TSHRMAPK1MEN1 | |
| SCHEMBL21587553 | 0.86 | ALDH1A1 (0.42) | ALDH1A1CYP3A4TSHRMAPK1MEN1 | |
| SCHEMBL28739951 | 0.84 | CYP3A4 (0.54) | ALDH1A1CYP3A4TSHRMEN1KMT2A | |
| SCHEMBL992694 | 0.84 | TSHR (0.65) | ALDH1A1CYP3A4TSHRMEN1KMT2A | |
| SCHEMBL16744306 | 0.82 | TSHR (0.62) | ALDH1A1CYP3A4TSHRMEN1KMT2A | |
| SCHEMBL832376 | 0.80 | MEN1 (0.58) | ALDH1A1CYP3A4TSHRMAPK1MEN1 | |
| SCHEMBL5024256 | 0.80 | MEN1 (0.58) | ALDH1A1CYP3A4TSHRMAPK1MEN1 | |
| SCHEMBL7634088 | 0.80 | CYP3A4 (0.39) | ALDH1A1CYP3A4TSHRMAPK1MEN1 | |
| SCHEMBL7634769 | 0.80 | CYP3A4 (0.39) | ALDH1A1CYP3A4TSHRMAPK1MEN1 | |
| SCHEMBL9187927 | 0.80 | CYP3A4 (0.77) | CYP3A4TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100267984-A1 | OXYFLUOROPHOSPHATE SYNTHESIS PROCESS AND COMPOUND THEREFROM | U.S. GOVERNMENT AS REPRESENTED BY THE SECRETARY OF THE ARMY (US) | 2010-10-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100267984-A1 | OXYFLUOROPHOSPHATE SYNTHESIS PROCESS AND COMPOUND THEREFROM | OXSR1, OR10J3, CA2 | ALDH1A1 3986/4885CYP3A4 1385/4885TSHR 449/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.